Affiliation:
1. Russian Medical Academy for Continuing Professional Education; I. M. Sechenov First Moscow State Medical University (Sechenov University)
2. Russian Medical Academy for Continuing Professional Education
3. I. M. Sechenov First Moscow State Medical University (Sechenov University)
Abstract
Some drugs can lead to the development of drug-induced arterial hypertension. The aim of the work is to systematize and analyze the data about drugs that can cause the development of drug-induced hypertension, as well as on epidemiology, pathophysiological mechanisms, risk factors, clinical picture, diagnosis and differential diagnosis, treatment and prevention of drug-induced hypertension. As a result of data analysis, it was revealed that drugs: glucocorticosteroids, antineoplastic drugs, immunosuppressants, nonsteroidal anti-inflammatory drugs, antidepressants and some others are associated with the development of hypertension. The mechanisms of development of drug-induced arterial hypertension are not fully established and require further study. Drug-induced arterial hypertension is still one of the most common and often unrecognized adverse reactions. The clinical manifestations of drug-induced hypertension are not specific. The symptoms are associated with target organ damage or complications of hypertension and may include a headache, nausea, dizziness, blurred vision, anxiety, shortness of breath, etc. patients with previously well-controlled hypertension or cases of uncontrolled hypertension. Therefore, it is always necessary to pay attention to the patient’s history, pharmacological anamnesis, rapid increases in blood pressure in patients with previously well-controlled hypertension, or cases of uncontrolled hypertension.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference56 articles.
1. Clinical guidelines. Arterial hypertension in adults. 2020. ID: КР62. Available: https://cr.minzdrav.gov.ru/schema/62_2. Accessed: 29.12.2021. (In Russ.)
2. Boytsov SA, Balanova YuA, Shalnova SA, Deev AD, Artamonova GV, Gatagonova TM, et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2014; 13 (4): 4–14. (In Russ.) https://doi.org/10.15829/1728–8800–2014–4–4–14.
3. Muromtseva GA, Kontsevaya AV, Konstantinov VV, Artamonova GV, Gatagonova TM, Duplyakov DV, et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012–2013 years. The results of ECVD-RF. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2014; 13 (6): 4–11. (In Russ.) https://doi.org/10.15829/1728–8800–2014–6–4–11
4. Tisdale JE, Miller DA. Drug Induced Diseases: Prevention, Detection, and Management. 3rd Ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018; 1399 р.
5. Ostroumova OD, Kulikova MI. Drug-induced arterial hypertension. Sistemnye gipertenzii = Systemic Hypertension. 2019; 16 (2): 32–41. (In Russ.) https://doi.org/10.26442/2075082X.2019.2.180164
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献